HIV Diagnostics Market, Global Outlook and Forecast 2022-2028
The HIV diagnostics market encompasses diagnostic screening and confirmatory tests for HIV-1, 2 and group O incidence testing. These tests have primary applications to screen and differentiate between the various groups and subtypes of human immunodeficiency virus.
This report contains market size and forecasts of HIV Diagnostics in Global, including the following market information:
Global HIV Diagnostics Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global HIV Diagnostics market was valued at 2712.5 million in 2021 and is projected to reach US$ 4690.9 million by 2028, at a CAGR of 8.1% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Consumables Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of HIV Diagnostics include Abbott, Abbott Healthcare, Abbvie Inc., Brsitol-Myers Squibb, Janssen Therapeutics, Gilead Sciences, Merck & Co. Inc, VIIV Healthcare and BD Biosciences, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the HIV Diagnostics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global HIV Diagnostics Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global HIV Diagnostics Market Segment Percentages, by Type, 2021 (%)
Global HIV Diagnostics Market Segment Percentages, by Application, 2021 (%)
Global HIV Diagnostics Market Segment Percentages, By Region and Country, 2021 (%)
The report also provides analysis of leading market participants including:
Key companies HIV Diagnostics revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies HIV Diagnostics revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
This report contains market size and forecasts of HIV Diagnostics in Global, including the following market information:
Global HIV Diagnostics Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global HIV Diagnostics market was valued at 2712.5 million in 2021 and is projected to reach US$ 4690.9 million by 2028, at a CAGR of 8.1% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Consumables Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of HIV Diagnostics include Abbott, Abbott Healthcare, Abbvie Inc., Brsitol-Myers Squibb, Janssen Therapeutics, Gilead Sciences, Merck & Co. Inc, VIIV Healthcare and BD Biosciences, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the HIV Diagnostics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global HIV Diagnostics Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global HIV Diagnostics Market Segment Percentages, by Type, 2021 (%)
- Consumables
- Assay, Kits and Reagents
- Other Consumables
- Instruments
- Software and Services
Global HIV Diagnostics Market Segment Percentages, by Application, 2021 (%)
- Antibody Tests
- Viral Load Tests
- CD4 Tests
- Tests for Early Infant Diagnosis
- Tests for Viral Identification
Global HIV Diagnostics Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
The report also provides analysis of leading market participants including:
Key companies HIV Diagnostics revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies HIV Diagnostics revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Abbott
- Abbott Healthcare
- Abbvie Inc.
- Brsitol-Myers Squibb
- Janssen Therapeutics
- Gilead Sciences
- Merck & Co. Inc
- VIIV Healthcare
- BD Biosciences
- Beckman Coulter
- Partec
- Sysmex
- Apogee Flow Systems
- PointCare Technologies Inc.
- Zyomyx Inc.
- Mylan inc.
- Roche Diagnostics
- Siemens Healthcare
- Qiagen
- BioMerieux
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS
1.1 HIV Diagnostics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global HIV Diagnostics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL HIV DIAGNOSTICS OVERALL MARKET SIZE
2.1 Global HIV Diagnostics Market Size: 2021 VS 2028
2.2 Global HIV Diagnostics Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 COMPANY LANDSCAPE
3.1 Top HIV Diagnostics Players in Global Market
3.2 Top Global HIV Diagnostics Companies Ranked by Revenue
3.3 Global HIV Diagnostics Revenue by Companies
3.4 Top 3 and Top 5 HIV Diagnostics Companies in Global Market, by Revenue in 2021
3.5 Global Companies HIV Diagnostics Product Type
3.6 Tier 1, Tier 2 and Tier 3 HIV Diagnostics Players in Global Market
3.6.1 List of Global Tier 1 HIV Diagnostics Companies
3.6.2 List of Global Tier 2 and Tier 3 HIV Diagnostics Companies
4 MARKET SIGHTS BY PRODUCT
4.1 Overview
4.1.1 by Type - Global HIV Diagnostics Market Size Markets, 2021 & 2028
4.1.2 Consumables
4.1.3 Assay, Kits and Reagents
4.1.4 Other Consumables
4.1.5 Instruments
4.1.6 Software and Services
4.2 By Type - Global HIV Diagnostics Revenue & Forecasts
4.2.1 By Type - Global HIV Diagnostics Revenue, 2017-2022
4.2.2 By Type - Global HIV Diagnostics Revenue, 2023-2028
4.2.3 By Type - Global HIV Diagnostics Revenue Market Share, 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global HIV Diagnostics Market Size, 2021 & 2028
5.1.2 Antibody Tests
5.1.3 Viral Load Tests
5.1.4 CD4 Tests
5.1.5 Tests for Early Infant Diagnosis
5.1.6 Tests for Viral Identification
5.2 By Application - Global HIV Diagnostics Revenue & Forecasts
5.2.1 By Application - Global HIV Diagnostics Revenue, 2017-2022
5.2.2 By Application - Global HIV Diagnostics Revenue, 2023-2028
5.2.3 By Application - Global HIV Diagnostics Revenue Market Share, 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global HIV Diagnostics Market Size, 2021 & 2028
6.2 By Region - Global HIV Diagnostics Revenue & Forecasts
6.2.1 By Region - Global HIV Diagnostics Revenue, 2017-2022
6.2.2 By Region - Global HIV Diagnostics Revenue, 2023-2028
6.2.3 By Region - Global HIV Diagnostics Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America HIV Diagnostics Revenue, 2017-2028
6.3.2 US HIV Diagnostics Market Size, 2017-2028
6.3.3 Canada HIV Diagnostics Market Size, 2017-2028
6.3.4 Mexico HIV Diagnostics Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe HIV Diagnostics Revenue, 2017-2028
6.4.2 Germany HIV Diagnostics Market Size, 2017-2028
6.4.3 France HIV Diagnostics Market Size, 2017-2028
6.4.4 U.K. HIV Diagnostics Market Size, 2017-2028
6.4.5 Italy HIV Diagnostics Market Size, 2017-2028
6.4.6 Russia HIV Diagnostics Market Size, 2017-2028
6.4.7 Nordic Countries HIV Diagnostics Market Size, 2017-2028
6.4.8 Benelux HIV Diagnostics Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia HIV Diagnostics Revenue, 2017-2028
6.5.2 China HIV Diagnostics Market Size, 2017-2028
6.5.3 Japan HIV Diagnostics Market Size, 2017-2028
6.5.4 South Korea HIV Diagnostics Market Size, 2017-2028
6.5.5 Southeast Asia HIV Diagnostics Market Size, 2017-2028
6.5.6 India HIV Diagnostics Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America HIV Diagnostics Revenue, 2017-2028
6.6.2 Brazil HIV Diagnostics Market Size, 2017-2028
6.6.3 Argentina HIV Diagnostics Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa HIV Diagnostics Revenue, 2017-2028
6.7.2 Turkey HIV Diagnostics Market Size, 2017-2028
6.7.3 Israel HIV Diagnostics Market Size, 2017-2028
6.7.4 Saudi Arabia HIV Diagnostics Market Size, 2017-2028
6.7.5 UAE HIV Diagnostics Market Size, 2017-2028
7 PLAYERS PROFILES
7.1 Abbott
7.1.1 Abbott Corporate Summary
7.1.2 Abbott Business Overview
7.1.3 Abbott HIV Diagnostics Major Product Offerings
7.1.4 Abbott HIV Diagnostics Revenue in Global Market (2017-2022)
7.1.5 Abbott Key News
7.2 Abbott Healthcare
7.2.1 Abbott Healthcare Corporate Summary
7.2.2 Abbott Healthcare Business Overview
7.2.3 Abbott Healthcare HIV Diagnostics Major Product Offerings
7.2.4 Abbott Healthcare HIV Diagnostics Revenue in Global Market (2017-2022)
7.2.5 Abbott Healthcare Key News
7.3 Abbvie Inc.
7.3.1 Abbvie Inc. Corporate Summary
7.3.2 Abbvie Inc. Business Overview
7.3.3 Abbvie Inc. HIV Diagnostics Major Product Offerings
7.3.4 Abbvie Inc. HIV Diagnostics Revenue in Global Market (2017-2022)
7.3.5 Abbvie Inc. Key News
7.4 Brsitol-Myers Squibb
7.4.1 Brsitol-Myers Squibb Corporate Summary
7.4.2 Brsitol-Myers Squibb Business Overview
7.4.3 Brsitol-Myers Squibb HIV Diagnostics Major Product Offerings
7.4.4 Brsitol-Myers Squibb HIV Diagnostics Revenue in Global Market (2017-2022)
7.4.5 Brsitol-Myers Squibb Key News
7.5 Janssen Therapeutics
7.5.1 Janssen Therapeutics Corporate Summary
7.5.2 Janssen Therapeutics Business Overview
7.5.3 Janssen Therapeutics HIV Diagnostics Major Product Offerings
7.5.4 Janssen Therapeutics HIV Diagnostics Revenue in Global Market (2017-2022)
7.5.5 Janssen Therapeutics Key News
7.6 Gilead Sciences
7.6.1 Gilead Sciences Corporate Summary
7.6.2 Gilead Sciences Business Overview
7.6.3 Gilead Sciences HIV Diagnostics Major Product Offerings
7.6.4 Gilead Sciences HIV Diagnostics Revenue in Global Market (2017-2022)
7.6.5 Gilead Sciences Key News
7.7 Merck & Co. Inc
7.7.1 Merck & Co. Inc Corporate Summary
7.7.2 Merck & Co. Inc Business Overview
7.7.3 Merck & Co. Inc HIV Diagnostics Major Product Offerings
7.7.4 Merck & Co. Inc HIV Diagnostics Revenue in Global Market (2017-2022)
7.7.5 Merck & Co. Inc Key News
7.8 VIIV Healthcare
7.8.1 VIIV Healthcare Corporate Summary
7.8.2 VIIV Healthcare Business Overview
7.8.3 VIIV Healthcare HIV Diagnostics Major Product Offerings
7.8.4 VIIV Healthcare HIV Diagnostics Revenue in Global Market (2017-2022)
7.8.5 VIIV Healthcare Key News
7.9 BD Biosciences
7.9.1 BD Biosciences Corporate Summary
7.9.2 BD Biosciences Business Overview
7.9.3 BD Biosciences HIV Diagnostics Major Product Offerings
7.9.4 BD Biosciences HIV Diagnostics Revenue in Global Market (2017-2022)
7.9.5 BD Biosciences Key News
7.10 Beckman Coulter
7.10.1 Beckman Coulter Corporate Summary
7.10.2 Beckman Coulter Business Overview
7.10.3 Beckman Coulter HIV Diagnostics Major Product Offerings
7.10.4 Beckman Coulter HIV Diagnostics Revenue in Global Market (2017-2022)
7.10.5 Beckman Coulter Key News
7.11 Partec
7.11.1 Partec Corporate Summary
7.11.2 Partec Business Overview
7.11.3 Partec HIV Diagnostics Major Product Offerings
7.11.4 Partec HIV Diagnostics Revenue in Global Market (2017-2022)
7.11.5 Partec Key News
7.12 Sysmex
7.12.1 Sysmex Corporate Summary
7.12.2 Sysmex Business Overview
7.12.3 Sysmex HIV Diagnostics Major Product Offerings
7.12.4 Sysmex HIV Diagnostics Revenue in Global Market (2017-2022)
7.12.5 Sysmex Key News
7.13 Apogee Flow Systems
7.13.1 Apogee Flow Systems Corporate Summary
7.13.2 Apogee Flow Systems Business Overview
7.13.3 Apogee Flow Systems HIV Diagnostics Major Product Offerings
7.13.4 Apogee Flow Systems HIV Diagnostics Revenue in Global Market (2017-2022)
7.13.5 Apogee Flow Systems Key News
7.14 PointCare Technologies Inc.
7.14.1 PointCare Technologies Inc. Corporate Summary
7.14.2 PointCare Technologies Inc. Business Overview
7.14.3 PointCare Technologies Inc. HIV Diagnostics Major Product Offerings
7.14.4 PointCare Technologies Inc. HIV Diagnostics Revenue in Global Market (2017-2022)
7.14.5 PointCare Technologies Inc. Key News
7.15 Zyomyx Inc.
7.15.1 Zyomyx Inc. Corporate Summary
7.15.2 Zyomyx Inc. Business Overview
7.15.3 Zyomyx Inc. HIV Diagnostics Major Product Offerings
7.15.4 Zyomyx Inc. HIV Diagnostics Revenue in Global Market (2017-2022)
7.15.5 Zyomyx Inc. Key News
7.16 Mylan inc.
7.16.1 Mylan inc. Corporate Summary
7.16.2 Mylan inc. Business Overview
7.16.3 Mylan inc. HIV Diagnostics Major Product Offerings
7.16.4 Mylan inc. HIV Diagnostics Revenue in Global Market (2017-2022)
7.16.5 Mylan inc. Key News
7.17 Roche Diagnostics
7.17.1 Roche Diagnostics Corporate Summary
7.17.2 Roche Diagnostics Business Overview
7.17.3 Roche Diagnostics HIV Diagnostics Major Product Offerings
7.17.4 Roche Diagnostics HIV Diagnostics Revenue in Global Market (2017-2022)
7.17.5 Roche Diagnostics Key News
7.18 Siemens Healthcare
7.18.1 Siemens Healthcare Corporate Summary
7.18.2 Siemens Healthcare Business Overview
7.18.3 Siemens Healthcare HIV Diagnostics Major Product Offerings
7.18.4 Siemens Healthcare HIV Diagnostics Revenue in Global Market (2017-2022)
7.18.5 Siemens Healthcare Key News
7.19 Qiagen
7.19.1 Qiagen Corporate Summary
7.19.2 Qiagen Business Overview
7.19.3 Qiagen HIV Diagnostics Major Product Offerings
7.19.4 Qiagen HIV Diagnostics Revenue in Global Market (2017-2022)
7.19.5 Qiagen Key News
7.20 BioMerieux
7.20.1 BioMerieux Corporate Summary
7.20.2 BioMerieux Business Overview
7.20.3 BioMerieux HIV Diagnostics Major Product Offerings
7.20.4 BioMerieux HIV Diagnostics Revenue in Global Market (2017-2022)
7.20.5 BioMerieux Key News
8 CONCLUSION
9 APPENDIX
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
1.1 HIV Diagnostics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global HIV Diagnostics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL HIV DIAGNOSTICS OVERALL MARKET SIZE
2.1 Global HIV Diagnostics Market Size: 2021 VS 2028
2.2 Global HIV Diagnostics Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 COMPANY LANDSCAPE
3.1 Top HIV Diagnostics Players in Global Market
3.2 Top Global HIV Diagnostics Companies Ranked by Revenue
3.3 Global HIV Diagnostics Revenue by Companies
3.4 Top 3 and Top 5 HIV Diagnostics Companies in Global Market, by Revenue in 2021
3.5 Global Companies HIV Diagnostics Product Type
3.6 Tier 1, Tier 2 and Tier 3 HIV Diagnostics Players in Global Market
3.6.1 List of Global Tier 1 HIV Diagnostics Companies
3.6.2 List of Global Tier 2 and Tier 3 HIV Diagnostics Companies
4 MARKET SIGHTS BY PRODUCT
4.1 Overview
4.1.1 by Type - Global HIV Diagnostics Market Size Markets, 2021 & 2028
4.1.2 Consumables
4.1.3 Assay, Kits and Reagents
4.1.4 Other Consumables
4.1.5 Instruments
4.1.6 Software and Services
4.2 By Type - Global HIV Diagnostics Revenue & Forecasts
4.2.1 By Type - Global HIV Diagnostics Revenue, 2017-2022
4.2.2 By Type - Global HIV Diagnostics Revenue, 2023-2028
4.2.3 By Type - Global HIV Diagnostics Revenue Market Share, 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global HIV Diagnostics Market Size, 2021 & 2028
5.1.2 Antibody Tests
5.1.3 Viral Load Tests
5.1.4 CD4 Tests
5.1.5 Tests for Early Infant Diagnosis
5.1.6 Tests for Viral Identification
5.2 By Application - Global HIV Diagnostics Revenue & Forecasts
5.2.1 By Application - Global HIV Diagnostics Revenue, 2017-2022
5.2.2 By Application - Global HIV Diagnostics Revenue, 2023-2028
5.2.3 By Application - Global HIV Diagnostics Revenue Market Share, 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global HIV Diagnostics Market Size, 2021 & 2028
6.2 By Region - Global HIV Diagnostics Revenue & Forecasts
6.2.1 By Region - Global HIV Diagnostics Revenue, 2017-2022
6.2.2 By Region - Global HIV Diagnostics Revenue, 2023-2028
6.2.3 By Region - Global HIV Diagnostics Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America HIV Diagnostics Revenue, 2017-2028
6.3.2 US HIV Diagnostics Market Size, 2017-2028
6.3.3 Canada HIV Diagnostics Market Size, 2017-2028
6.3.4 Mexico HIV Diagnostics Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe HIV Diagnostics Revenue, 2017-2028
6.4.2 Germany HIV Diagnostics Market Size, 2017-2028
6.4.3 France HIV Diagnostics Market Size, 2017-2028
6.4.4 U.K. HIV Diagnostics Market Size, 2017-2028
6.4.5 Italy HIV Diagnostics Market Size, 2017-2028
6.4.6 Russia HIV Diagnostics Market Size, 2017-2028
6.4.7 Nordic Countries HIV Diagnostics Market Size, 2017-2028
6.4.8 Benelux HIV Diagnostics Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia HIV Diagnostics Revenue, 2017-2028
6.5.2 China HIV Diagnostics Market Size, 2017-2028
6.5.3 Japan HIV Diagnostics Market Size, 2017-2028
6.5.4 South Korea HIV Diagnostics Market Size, 2017-2028
6.5.5 Southeast Asia HIV Diagnostics Market Size, 2017-2028
6.5.6 India HIV Diagnostics Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America HIV Diagnostics Revenue, 2017-2028
6.6.2 Brazil HIV Diagnostics Market Size, 2017-2028
6.6.3 Argentina HIV Diagnostics Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa HIV Diagnostics Revenue, 2017-2028
6.7.2 Turkey HIV Diagnostics Market Size, 2017-2028
6.7.3 Israel HIV Diagnostics Market Size, 2017-2028
6.7.4 Saudi Arabia HIV Diagnostics Market Size, 2017-2028
6.7.5 UAE HIV Diagnostics Market Size, 2017-2028
7 PLAYERS PROFILES
7.1 Abbott
7.1.1 Abbott Corporate Summary
7.1.2 Abbott Business Overview
7.1.3 Abbott HIV Diagnostics Major Product Offerings
7.1.4 Abbott HIV Diagnostics Revenue in Global Market (2017-2022)
7.1.5 Abbott Key News
7.2 Abbott Healthcare
7.2.1 Abbott Healthcare Corporate Summary
7.2.2 Abbott Healthcare Business Overview
7.2.3 Abbott Healthcare HIV Diagnostics Major Product Offerings
7.2.4 Abbott Healthcare HIV Diagnostics Revenue in Global Market (2017-2022)
7.2.5 Abbott Healthcare Key News
7.3 Abbvie Inc.
7.3.1 Abbvie Inc. Corporate Summary
7.3.2 Abbvie Inc. Business Overview
7.3.3 Abbvie Inc. HIV Diagnostics Major Product Offerings
7.3.4 Abbvie Inc. HIV Diagnostics Revenue in Global Market (2017-2022)
7.3.5 Abbvie Inc. Key News
7.4 Brsitol-Myers Squibb
7.4.1 Brsitol-Myers Squibb Corporate Summary
7.4.2 Brsitol-Myers Squibb Business Overview
7.4.3 Brsitol-Myers Squibb HIV Diagnostics Major Product Offerings
7.4.4 Brsitol-Myers Squibb HIV Diagnostics Revenue in Global Market (2017-2022)
7.4.5 Brsitol-Myers Squibb Key News
7.5 Janssen Therapeutics
7.5.1 Janssen Therapeutics Corporate Summary
7.5.2 Janssen Therapeutics Business Overview
7.5.3 Janssen Therapeutics HIV Diagnostics Major Product Offerings
7.5.4 Janssen Therapeutics HIV Diagnostics Revenue in Global Market (2017-2022)
7.5.5 Janssen Therapeutics Key News
7.6 Gilead Sciences
7.6.1 Gilead Sciences Corporate Summary
7.6.2 Gilead Sciences Business Overview
7.6.3 Gilead Sciences HIV Diagnostics Major Product Offerings
7.6.4 Gilead Sciences HIV Diagnostics Revenue in Global Market (2017-2022)
7.6.5 Gilead Sciences Key News
7.7 Merck & Co. Inc
7.7.1 Merck & Co. Inc Corporate Summary
7.7.2 Merck & Co. Inc Business Overview
7.7.3 Merck & Co. Inc HIV Diagnostics Major Product Offerings
7.7.4 Merck & Co. Inc HIV Diagnostics Revenue in Global Market (2017-2022)
7.7.5 Merck & Co. Inc Key News
7.8 VIIV Healthcare
7.8.1 VIIV Healthcare Corporate Summary
7.8.2 VIIV Healthcare Business Overview
7.8.3 VIIV Healthcare HIV Diagnostics Major Product Offerings
7.8.4 VIIV Healthcare HIV Diagnostics Revenue in Global Market (2017-2022)
7.8.5 VIIV Healthcare Key News
7.9 BD Biosciences
7.9.1 BD Biosciences Corporate Summary
7.9.2 BD Biosciences Business Overview
7.9.3 BD Biosciences HIV Diagnostics Major Product Offerings
7.9.4 BD Biosciences HIV Diagnostics Revenue in Global Market (2017-2022)
7.9.5 BD Biosciences Key News
7.10 Beckman Coulter
7.10.1 Beckman Coulter Corporate Summary
7.10.2 Beckman Coulter Business Overview
7.10.3 Beckman Coulter HIV Diagnostics Major Product Offerings
7.10.4 Beckman Coulter HIV Diagnostics Revenue in Global Market (2017-2022)
7.10.5 Beckman Coulter Key News
7.11 Partec
7.11.1 Partec Corporate Summary
7.11.2 Partec Business Overview
7.11.3 Partec HIV Diagnostics Major Product Offerings
7.11.4 Partec HIV Diagnostics Revenue in Global Market (2017-2022)
7.11.5 Partec Key News
7.12 Sysmex
7.12.1 Sysmex Corporate Summary
7.12.2 Sysmex Business Overview
7.12.3 Sysmex HIV Diagnostics Major Product Offerings
7.12.4 Sysmex HIV Diagnostics Revenue in Global Market (2017-2022)
7.12.5 Sysmex Key News
7.13 Apogee Flow Systems
7.13.1 Apogee Flow Systems Corporate Summary
7.13.2 Apogee Flow Systems Business Overview
7.13.3 Apogee Flow Systems HIV Diagnostics Major Product Offerings
7.13.4 Apogee Flow Systems HIV Diagnostics Revenue in Global Market (2017-2022)
7.13.5 Apogee Flow Systems Key News
7.14 PointCare Technologies Inc.
7.14.1 PointCare Technologies Inc. Corporate Summary
7.14.2 PointCare Technologies Inc. Business Overview
7.14.3 PointCare Technologies Inc. HIV Diagnostics Major Product Offerings
7.14.4 PointCare Technologies Inc. HIV Diagnostics Revenue in Global Market (2017-2022)
7.14.5 PointCare Technologies Inc. Key News
7.15 Zyomyx Inc.
7.15.1 Zyomyx Inc. Corporate Summary
7.15.2 Zyomyx Inc. Business Overview
7.15.3 Zyomyx Inc. HIV Diagnostics Major Product Offerings
7.15.4 Zyomyx Inc. HIV Diagnostics Revenue in Global Market (2017-2022)
7.15.5 Zyomyx Inc. Key News
7.16 Mylan inc.
7.16.1 Mylan inc. Corporate Summary
7.16.2 Mylan inc. Business Overview
7.16.3 Mylan inc. HIV Diagnostics Major Product Offerings
7.16.4 Mylan inc. HIV Diagnostics Revenue in Global Market (2017-2022)
7.16.5 Mylan inc. Key News
7.17 Roche Diagnostics
7.17.1 Roche Diagnostics Corporate Summary
7.17.2 Roche Diagnostics Business Overview
7.17.3 Roche Diagnostics HIV Diagnostics Major Product Offerings
7.17.4 Roche Diagnostics HIV Diagnostics Revenue in Global Market (2017-2022)
7.17.5 Roche Diagnostics Key News
7.18 Siemens Healthcare
7.18.1 Siemens Healthcare Corporate Summary
7.18.2 Siemens Healthcare Business Overview
7.18.3 Siemens Healthcare HIV Diagnostics Major Product Offerings
7.18.4 Siemens Healthcare HIV Diagnostics Revenue in Global Market (2017-2022)
7.18.5 Siemens Healthcare Key News
7.19 Qiagen
7.19.1 Qiagen Corporate Summary
7.19.2 Qiagen Business Overview
7.19.3 Qiagen HIV Diagnostics Major Product Offerings
7.19.4 Qiagen HIV Diagnostics Revenue in Global Market (2017-2022)
7.19.5 Qiagen Key News
7.20 BioMerieux
7.20.1 BioMerieux Corporate Summary
7.20.2 BioMerieux Business Overview
7.20.3 BioMerieux HIV Diagnostics Major Product Offerings
7.20.4 BioMerieux HIV Diagnostics Revenue in Global Market (2017-2022)
7.20.5 BioMerieux Key News
8 CONCLUSION
9 APPENDIX
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES
Table 1. HIV Diagnostics Market Opportunities & Trends in Global Market
Table 2. HIV Diagnostics Market Drivers in Global Market
Table 3. HIV Diagnostics Market Restraints in Global Market
Table 4. Key Players of HIV Diagnostics in Global Market
Table 5. Top HIV Diagnostics Players in Global Market, Ranking by Revenue (2021)
Table 6. Global HIV Diagnostics Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global HIV Diagnostics Revenue Share by Companies, 2017-2022
Table 8. Global Companies HIV Diagnostics Product Type
Table 9. List of Global Tier 1 HIV Diagnostics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 HIV Diagnostics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global HIV Diagnostics Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - HIV Diagnostics Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - HIV Diagnostics Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global HIV Diagnostics Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - HIV Diagnostics Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - HIV Diagnostics Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global HIV Diagnostics Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global HIV Diagnostics Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global HIV Diagnostics Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America HIV Diagnostics Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America HIV Diagnostics Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe HIV Diagnostics Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe HIV Diagnostics Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia HIV Diagnostics Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia HIV Diagnostics Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America HIV Diagnostics Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America HIV Diagnostics Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa HIV Diagnostics Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa HIV Diagnostics Revenue, (US$, Mn), 2023-2028
Table 30. Abbott Corporate Summary
Table 31. Abbott HIV Diagnostics Product Offerings
Table 32. Abbott HIV Diagnostics Revenue (US$, Mn), (2017-2022)
Table 33. Abbott Healthcare Corporate Summary
Table 34. Abbott Healthcare HIV Diagnostics Product Offerings
Table 35. Abbott Healthcare HIV Diagnostics Revenue (US$, Mn), (2017-2022)
Table 36. Abbvie Inc. Corporate Summary
Table 37. Abbvie Inc. HIV Diagnostics Product Offerings
Table 38. Abbvie Inc. HIV Diagnostics Revenue (US$, Mn), (2017-2022)
Table 39. Brsitol-Myers Squibb Corporate Summary
Table 40. Brsitol-Myers Squibb HIV Diagnostics Product Offerings
Table 41. Brsitol-Myers Squibb HIV Diagnostics Revenue (US$, Mn), (2017-2022)
Table 42. Janssen Therapeutics Corporate Summary
Table 43. Janssen Therapeutics HIV Diagnostics Product Offerings
Table 44. Janssen Therapeutics HIV Diagnostics Revenue (US$, Mn), (2017-2022)
Table 45. Gilead Sciences Corporate Summary
Table 46. Gilead Sciences HIV Diagnostics Product Offerings
Table 47. Gilead Sciences HIV Diagnostics Revenue (US$, Mn), (2017-2022)
Table 48. Merck & Co. Inc Corporate Summary
Table 49. Merck & Co. Inc HIV Diagnostics Product Offerings
Table 50. Merck & Co. Inc HIV Diagnostics Revenue (US$, Mn), (2017-2022)
Table 51. VIIV Healthcare Corporate Summary
Table 52. VIIV Healthcare HIV Diagnostics Product Offerings
Table 53. VIIV Healthcare HIV Diagnostics Revenue (US$, Mn), (2017-2022)
Table 54. BD Biosciences Corporate Summary
Table 55. BD Biosciences HIV Diagnostics Product Offerings
Table 56. BD Biosciences HIV Diagnostics Revenue (US$, Mn), (2017-2022)
Table 57. Beckman Coulter Corporate Summary
Table 58. Beckman Coulter HIV Diagnostics Product Offerings
Table 59. Beckman Coulter HIV Diagnostics Revenue (US$, Mn), (2017-2022)
Table 60. Partec Corporate Summary
Table 61. Partec HIV Diagnostics Product Offerings
Table 62. Partec HIV Diagnostics Revenue (US$, Mn), (2017-2022)
Table 63. Sysmex Corporate Summary
Table 64. Sysmex HIV Diagnostics Product Offerings
Table 65. Sysmex HIV Diagnostics Revenue (US$, Mn), (2017-2022)
Table 66. Apogee Flow Systems Corporate Summary
Table 67. Apogee Flow Systems HIV Diagnostics Product Offerings
Table 68. Apogee Flow Systems HIV Diagnostics Revenue (US$, Mn), (2017-2022)
Table 69. PointCare Technologies Inc. Corporate Summary
Table 70. PointCare Technologies Inc. HIV Diagnostics Product Offerings
Table 71. PointCare Technologies Inc. HIV Diagnostics Revenue (US$, Mn), (2017-2022)
Table 72. Zyomyx Inc. Corporate Summary
Table 73. Zyomyx Inc. HIV Diagnostics Product Offerings
Table 74. Zyomyx Inc. HIV Diagnostics Revenue (US$, Mn), (2017-2022)
Table 75. Mylan inc. Corporate Summary
Table 76. Mylan inc. HIV Diagnostics Product Offerings
Table 77. Mylan inc. HIV Diagnostics Revenue (US$, Mn), (2017-2022)
Table 78. Roche Diagnostics Corporate Summary
Table 79. Roche Diagnostics HIV Diagnostics Product Offerings
Table 80. Roche Diagnostics HIV Diagnostics Revenue (US$, Mn), (2017-2022)
Table 81. Siemens Healthcare Corporate Summary
Table 82. Siemens Healthcare HIV Diagnostics Product Offerings
Table 83. Siemens Healthcare HIV Diagnostics Revenue (US$, Mn), (2017-2022)
Table 84. Qiagen Corporate Summary
Table 85. Qiagen HIV Diagnostics Product Offerings
Table 86. Qiagen HIV Diagnostics Revenue (US$, Mn), (2017-2022)
Table 87. BioMerieux Corporate Summary
Table 88. BioMerieux HIV Diagnostics Product Offerings
Table 89. BioMerieux HIV Diagnostics Revenue (US$, Mn), (2017-2022)
Table 1. HIV Diagnostics Market Opportunities & Trends in Global Market
Table 2. HIV Diagnostics Market Drivers in Global Market
Table 3. HIV Diagnostics Market Restraints in Global Market
Table 4. Key Players of HIV Diagnostics in Global Market
Table 5. Top HIV Diagnostics Players in Global Market, Ranking by Revenue (2021)
Table 6. Global HIV Diagnostics Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global HIV Diagnostics Revenue Share by Companies, 2017-2022
Table 8. Global Companies HIV Diagnostics Product Type
Table 9. List of Global Tier 1 HIV Diagnostics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 HIV Diagnostics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global HIV Diagnostics Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - HIV Diagnostics Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - HIV Diagnostics Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global HIV Diagnostics Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - HIV Diagnostics Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - HIV Diagnostics Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global HIV Diagnostics Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global HIV Diagnostics Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global HIV Diagnostics Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America HIV Diagnostics Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America HIV Diagnostics Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe HIV Diagnostics Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe HIV Diagnostics Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia HIV Diagnostics Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia HIV Diagnostics Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America HIV Diagnostics Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America HIV Diagnostics Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa HIV Diagnostics Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa HIV Diagnostics Revenue, (US$, Mn), 2023-2028
Table 30. Abbott Corporate Summary
Table 31. Abbott HIV Diagnostics Product Offerings
Table 32. Abbott HIV Diagnostics Revenue (US$, Mn), (2017-2022)
Table 33. Abbott Healthcare Corporate Summary
Table 34. Abbott Healthcare HIV Diagnostics Product Offerings
Table 35. Abbott Healthcare HIV Diagnostics Revenue (US$, Mn), (2017-2022)
Table 36. Abbvie Inc. Corporate Summary
Table 37. Abbvie Inc. HIV Diagnostics Product Offerings
Table 38. Abbvie Inc. HIV Diagnostics Revenue (US$, Mn), (2017-2022)
Table 39. Brsitol-Myers Squibb Corporate Summary
Table 40. Brsitol-Myers Squibb HIV Diagnostics Product Offerings
Table 41. Brsitol-Myers Squibb HIV Diagnostics Revenue (US$, Mn), (2017-2022)
Table 42. Janssen Therapeutics Corporate Summary
Table 43. Janssen Therapeutics HIV Diagnostics Product Offerings
Table 44. Janssen Therapeutics HIV Diagnostics Revenue (US$, Mn), (2017-2022)
Table 45. Gilead Sciences Corporate Summary
Table 46. Gilead Sciences HIV Diagnostics Product Offerings
Table 47. Gilead Sciences HIV Diagnostics Revenue (US$, Mn), (2017-2022)
Table 48. Merck & Co. Inc Corporate Summary
Table 49. Merck & Co. Inc HIV Diagnostics Product Offerings
Table 50. Merck & Co. Inc HIV Diagnostics Revenue (US$, Mn), (2017-2022)
Table 51. VIIV Healthcare Corporate Summary
Table 52. VIIV Healthcare HIV Diagnostics Product Offerings
Table 53. VIIV Healthcare HIV Diagnostics Revenue (US$, Mn), (2017-2022)
Table 54. BD Biosciences Corporate Summary
Table 55. BD Biosciences HIV Diagnostics Product Offerings
Table 56. BD Biosciences HIV Diagnostics Revenue (US$, Mn), (2017-2022)
Table 57. Beckman Coulter Corporate Summary
Table 58. Beckman Coulter HIV Diagnostics Product Offerings
Table 59. Beckman Coulter HIV Diagnostics Revenue (US$, Mn), (2017-2022)
Table 60. Partec Corporate Summary
Table 61. Partec HIV Diagnostics Product Offerings
Table 62. Partec HIV Diagnostics Revenue (US$, Mn), (2017-2022)
Table 63. Sysmex Corporate Summary
Table 64. Sysmex HIV Diagnostics Product Offerings
Table 65. Sysmex HIV Diagnostics Revenue (US$, Mn), (2017-2022)
Table 66. Apogee Flow Systems Corporate Summary
Table 67. Apogee Flow Systems HIV Diagnostics Product Offerings
Table 68. Apogee Flow Systems HIV Diagnostics Revenue (US$, Mn), (2017-2022)
Table 69. PointCare Technologies Inc. Corporate Summary
Table 70. PointCare Technologies Inc. HIV Diagnostics Product Offerings
Table 71. PointCare Technologies Inc. HIV Diagnostics Revenue (US$, Mn), (2017-2022)
Table 72. Zyomyx Inc. Corporate Summary
Table 73. Zyomyx Inc. HIV Diagnostics Product Offerings
Table 74. Zyomyx Inc. HIV Diagnostics Revenue (US$, Mn), (2017-2022)
Table 75. Mylan inc. Corporate Summary
Table 76. Mylan inc. HIV Diagnostics Product Offerings
Table 77. Mylan inc. HIV Diagnostics Revenue (US$, Mn), (2017-2022)
Table 78. Roche Diagnostics Corporate Summary
Table 79. Roche Diagnostics HIV Diagnostics Product Offerings
Table 80. Roche Diagnostics HIV Diagnostics Revenue (US$, Mn), (2017-2022)
Table 81. Siemens Healthcare Corporate Summary
Table 82. Siemens Healthcare HIV Diagnostics Product Offerings
Table 83. Siemens Healthcare HIV Diagnostics Revenue (US$, Mn), (2017-2022)
Table 84. Qiagen Corporate Summary
Table 85. Qiagen HIV Diagnostics Product Offerings
Table 86. Qiagen HIV Diagnostics Revenue (US$, Mn), (2017-2022)
Table 87. BioMerieux Corporate Summary
Table 88. BioMerieux HIV Diagnostics Product Offerings
Table 89. BioMerieux HIV Diagnostics Revenue (US$, Mn), (2017-2022)
LIST OF FIGURES
Figure 1. HIV Diagnostics Segment by Type in 2021
Figure 2. HIV Diagnostics Segment by Application in 2021
Figure 3. Global HIV Diagnostics Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global HIV Diagnostics Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global HIV Diagnostics Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by HIV Diagnostics Revenue in 2021
Figure 8. By Type - Global HIV Diagnostics Revenue Market Share, 2017-2028
Figure 9. By Application - Global HIV Diagnostics Revenue Market Share, 2017-2028
Figure 10. By Region - Global HIV Diagnostics Revenue Market Share, 2017-2028
Figure 11. By Country - North America HIV Diagnostics Revenue Market Share, 2017-2028
Figure 12. US HIV Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 13. Canada HIV Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico HIV Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe HIV Diagnostics Revenue Market Share, 2017-2028
Figure 16. Germany HIV Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 17. France HIV Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. HIV Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 19. Italy HIV Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 20. Russia HIV Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries HIV Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux HIV Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia HIV Diagnostics Revenue Market Share, 2017-2028
Figure 24. China HIV Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 25. Japan HIV Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea HIV Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia HIV Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 28. India HIV Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America HIV Diagnostics Revenue Market Share, 2017-2028
Figure 30. Brazil HIV Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina HIV Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa HIV Diagnostics Revenue Market Share, 2017-2028
Figure 33. Turkey HIV Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 34. Israel HIV Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia HIV Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 36. UAE HIV Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 37. Abbott HIV Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Abbott Healthcare HIV Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Abbvie Inc. HIV Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Brsitol-Myers Squibb HIV Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Janssen Therapeutics HIV Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Gilead Sciences HIV Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Merck & Co. Inc HIV Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. VIIV Healthcare HIV Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. BD Biosciences HIV Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Beckman Coulter HIV Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Partec HIV Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Sysmex HIV Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. Apogee Flow Systems HIV Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 50. PointCare Technologies Inc. HIV Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 51. Zyomyx Inc. HIV Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 52. Mylan inc. HIV Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 53. Roche Diagnostics HIV Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 54. Siemens Healthcare HIV Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 55. Qiagen HIV Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 56. BioMerieux HIV Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 1. HIV Diagnostics Segment by Type in 2021
Figure 2. HIV Diagnostics Segment by Application in 2021
Figure 3. Global HIV Diagnostics Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global HIV Diagnostics Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global HIV Diagnostics Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by HIV Diagnostics Revenue in 2021
Figure 8. By Type - Global HIV Diagnostics Revenue Market Share, 2017-2028
Figure 9. By Application - Global HIV Diagnostics Revenue Market Share, 2017-2028
Figure 10. By Region - Global HIV Diagnostics Revenue Market Share, 2017-2028
Figure 11. By Country - North America HIV Diagnostics Revenue Market Share, 2017-2028
Figure 12. US HIV Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 13. Canada HIV Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico HIV Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe HIV Diagnostics Revenue Market Share, 2017-2028
Figure 16. Germany HIV Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 17. France HIV Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. HIV Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 19. Italy HIV Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 20. Russia HIV Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries HIV Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux HIV Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia HIV Diagnostics Revenue Market Share, 2017-2028
Figure 24. China HIV Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 25. Japan HIV Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea HIV Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia HIV Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 28. India HIV Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America HIV Diagnostics Revenue Market Share, 2017-2028
Figure 30. Brazil HIV Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina HIV Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa HIV Diagnostics Revenue Market Share, 2017-2028
Figure 33. Turkey HIV Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 34. Israel HIV Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia HIV Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 36. UAE HIV Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 37. Abbott HIV Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Abbott Healthcare HIV Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Abbvie Inc. HIV Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Brsitol-Myers Squibb HIV Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Janssen Therapeutics HIV Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Gilead Sciences HIV Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Merck & Co. Inc HIV Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. VIIV Healthcare HIV Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. BD Biosciences HIV Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Beckman Coulter HIV Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Partec HIV Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Sysmex HIV Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. Apogee Flow Systems HIV Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 50. PointCare Technologies Inc. HIV Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 51. Zyomyx Inc. HIV Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 52. Mylan inc. HIV Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 53. Roche Diagnostics HIV Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 54. Siemens Healthcare HIV Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 55. Qiagen HIV Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 56. BioMerieux HIV Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
